AzTrials
AzTrials

Upper Limb RehabilitationNCT03752775

Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke

A study testing Robot assisted upper limb rehabilitation in people with Upper Limb Rehabilitation, run by The Hong Kong Polytechnic University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

A new clothing robotic arm was developed for multi-joint coordinated upper limb rehabilitation after stroke. Patients after stroke will be recruited to evaluate the rehabilitation effectiveness of the device assisted upper limb rehabilitation. Both patients with chronic stroke and subacute stroke will be investigated. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Upper Limb Rehabilitation
What is being tested?
Robot assisted upper limb rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteChina
Study dates
1 Nov 2018to 31 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • For the subacute groups:
  • Two weeks after the onset of stroke, however less than 0.5 year
  • Mini-Mental State Examination (MMSE)>21
  • Able to sit up for at least 1 hour
  • Fugl-Meyer Assessment (FMA) upper limb <30
  • Modified Ashworth Score (MAS) at the elbow, wrist and fingers <3
Show all 14Show fewer
  • Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline)
  • For the chronic device assisted group:
  • At least 0.5 year after the onset of stroke
  • Mini-Mental State Examination (MMSE)>21
  • Able to sit up for at least 1 hour
  • Fugl-Meyer Assessment (FMA) upper limb <30
  • Modified Ashworth Score (MAS) at the elbow, wrist and fingers <3
  • Detectable EMG on the target driving muscles (i.e., 3 times of the standard deviation above the baseline)

Who cannot join

  • Subjects will be excluded if they do not meet the above inclusion criteria, or had the following conditions:
  • Currently pregnant
  • Dysphasia (language deficiency)
  • Post-stroke neglect
  • Pacemaker implantation,
  • Involved in drug studies, other clinical trials, or concurrent medication/occupational/physical treatments on the upper limb
  • The overall medical condition not suitable for the training (e.g., severe cardiac problem, unstable blood pressure, etc.).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Xiaoling Hu, PhD contact

34003206

xiaoling.hu@polyu.edu.hk

China1 site, 1 recruiting
  • The Hong Kong Polytechnic University

    Hong Kong

    Xiaoling Hu, Ph.D., +852 34003205, xiaoling.hu@polyu.edu.hk

    Xiaoling Hu, Ph.D.

    Recruiting

Other trials in China

About this study

Official title: Mobile Electromyography (EMG)-Driven Exoneuromusculoskeleton for Upper Limb Rehabilitation After Stroke

A new clothing robotic arm was developed for multi-joint coordinated upper limb rehabilitation after stroke. Patients after stroke will be recruited to evaluate the rehabilitation effectiveness of the device assisted upper limb rehabilitation. Both patients with chronic stroke and subacute stroke will be investigated.

Read the detailed description

A new robotic arm, named mobile exo-neuro-musculo-skeleton, was developed for upper limb rehabilitation. The system integrated the advantages of exoskeleton, soft robot, and neuromuscular electrical stimulation. It is noninvasive, light in weight, comfortable to wear, and can support the motions at the elbow, the wrist and the fingers. The device is a mobile system interfaced with a mobile app by a user.

The device assisted upper limb rehabilitation will be applied to inpatients with subacute stroke. The rehabilitation effects on the motor restoration in the upper limb will be compared with the conventional physical and occupational therapies. The rehabilitation effects of the device assisted training also will be evaluated on patients with chronic stroke. The motor improvements after training will be investigated by comparing the pre- and post- clinical assessments. It is hypothesized that the device assisted upper limb rehabilitation will be effective in both subacute and chronic patients.

Being tested
Robot assisted upper limb rehabilitation
Keywords
stroke, upper limb, Joint coordination
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Robot assisted upper limb rehabilitationDevice

    The patients in the experimental and the other arms will receive 20 session device assisted upper limb rehabilitation. In each session, a subject will conduct multi-joint coordinated upper limb motions for 1 hour.

Study groups in NCT03752775
Study groupRoleWhat they receive
subacute device assisted groupExperimentalNot described
Receives: Device: Robot assisted upper limb rehabilitation
subacute conventional groupActive comparatorNot described
Receives: Device: Robot assisted upper limb rehabilitation
chronic device assisted groupOtherNot described
Receives: Device: Robot assisted upper limb rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment (FMA) of the Upper Limb before the training

    Measured: For each subject, the FMA score will be measured one day before the training.

  2. Fugl-Meyer Assessment (FMA) of the Upper Limb after the training

    Measured: For each subject, the FMA score will be measured one day after the 20-session training program.

  3. Fugl-Meyer Assessment (FMA) of the Upper Limb 3-month follow-up

    Measured: For each subject, the FMA score will be measured 3 months later after the last day of the training.

Secondary outcomes (2)
  1. Modified Ashworth Scale (MAS)

    Measured: For each subject, the MAS score will be measure one day before the training, one day after the 20-session training program, and 3 months later after the last day of the training.

  2. Action Research Arm Test (ARAT)

    Measured: For each subject, the ARAT score will be measure one day before the training, one day after the 20-session training program, and 3 months later after the last day of the training.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2018
  2. Study start1 Nov 2018
  3. Primary completion31 Dec 2027 (estimated)
  4. Study completion31 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The device assisted treatment will be administrated to patients with subacute stroke and chronic stroke. The subacute stroke group will be compared in parallel with a control group receive the conventional physical and occupational therapies.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03752775
Sponsor's protocol ID
ITS/073/16
Status last verified
Jun 2026
First submitted
20 Nov 2018
Last updated
23 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nam C, Zhang B, Chow T, Ye F, Huang Y, Guo Z, Li W, Rong W, Hu X, Poon W. Home-based self-help telerehabilitation of the upper limb assisted by an electromyography-driven wrist/hand exoneuromusculoskeleton after stroke. J Neuroeng Rehabil. 2021 Sep 15;18(1):137. doi: 10.1186/s12984-021-00930-3.

    PubMed 34526058
  • Nam C, Rong W, Li W, Cheung C, Ngai W, Cheung T, Pang M, Li L, Hu J, Wai H, Hu X. An Exoneuromusculoskeleton for Self-Help Upper Limb Rehabilitation After Stroke. Soft Robot. 2022 Feb;9(1):14-35. doi: 10.1089/soro.2020.0090. Epub 2020 Dec 3.

    PubMed 33271057

Questions about this trial

What is this clinical trial studying?

A study testing Robot assisted upper limb rehabilitation in people with Upper Limb Rehabilitation, run by The Hong Kong Polytechnic University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xiaoling Hu, PhD (34003206, xiaoling.hu@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment (FMA) of the Upper Limb before the training (time frame: For each subject, the FMA score will be measured one day before the training.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03752775, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in